Latest / Stock Movers / Nvidia Moves Higher; Pfizer in Shutdown Flux; Rumble Rises
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio News, The.
- 0:08Speaker 2: Stock Movers Report, your roundup of companies making moves in
- 0:12Speaker 2: the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 3: Let's take a look at some stocks on the move today.
- 0:18Speaker 3: I'm Nathan Hager, joined by Bloomberg's Valerie Titel on a
- 0:22Speaker 3: comeback Monday, and one of the stocks in the midst
- 0:25Speaker 3: of the comeback is the biggest of all. Valerie, good morning.
- 0:30Speaker 1: Hey, good morning, Nathan. Happy Monday. Yes, Nvidia is leading
- 0:33Speaker 1: the gains across the mag seven on this broad rebound,
- 0:37Speaker 1: on these hopes of this government shutdown ending really taking
- 0:40Speaker 1: a lot of the focus and the worries about this
- 0:42Speaker 1: AI trade. I guess off the main path at the moment.
- 0:46Speaker 1: Nvidia up three point two percent now. It did have
- 0:49Speaker 1: its worst week last week since early April. It was
- 0:53Speaker 1: down around seven percent on the week last week, so
- 0:55Speaker 1: we're making up nearly half of the losses with this
- 0:58Speaker 1: pre market move for Nvidiao. Overnight, we did have the
- 1:02Speaker 1: CEO Jensen Kwang. He was in Taipei, his third visit
- 1:05Speaker 1: to Taiwan in the last three months, meeting with TSMC
- 1:09Speaker 1: asking for additional supply from TSMC, with the CEO saying
- 1:13Speaker 1: he has asked them for more chip supplies to keep
- 1:15Speaker 1: up with booming AI demands. So there's also a positive
- 1:18Speaker 1: sentiment as well at the back of this on this rebound.
- 1:21Speaker 3: Althoth though, I guess there is a one sector in
- 1:23Speaker 3: particular that's seeing some negative sentiment around the government shutdown
- 1:28Speaker 3: getting resolved.
- 1:29Speaker 1: Yeah, that's the health insurance sector is really on a
- 1:34Speaker 1: back foot. We have the likes of Senting down over
- 1:37Speaker 1: eight percent, OSCAR health down eight and a half, and
- 1:40Speaker 1: this comes after that Democrats are looking like they will
- 1:43Speaker 1: concede in the shutdown fight without securing a win for
- 1:47Speaker 1: healthcare payments. When it comes to the Affordable Care Act
- 1:49Speaker 1: subsidies now scenting an OSCAR are some of the biggest
- 1:52Speaker 1: providers of coverage under ACA, also known as Obambacare. We
- 1:57Speaker 1: also had President Trump out in a series of truth
- 2:00Speaker 1: social posts saying that the hundreds of billions of dollars
- 2:03Speaker 1: and federal funding that goes to these health insurers under
- 2:06Speaker 1: ACA should be sent directly to the public instead. So
- 2:09Speaker 1: double whammy for these health insurance name the whole sector
- 2:12Speaker 1: really on a back foot, sent in an OSCAR being
- 2:14Speaker 1: the main losers.
- 2:15Speaker 3: And staying in the healthcare sector of sorts. Could it
- 2:17Speaker 3: be that the met Sarah saga is coming to an
- 2:21Speaker 3: end along with the government shutdown.
- 2:23Speaker 1: Yeah, it does seem like Pfizer has ended the bidding
- 2:26Speaker 1: war for a met Sarah that's the obesit startup that
- 2:29Speaker 1: was both eyed by Peiser and by Novo Nordis. We're
- 2:33Speaker 1: seeing some share price moves off the back of this,
- 2:35Speaker 1: mostly due to met Sarah down nearly fifteen percent in
- 2:38Speaker 1: the pre market. Maybe it seemed that the market had
- 2:41Speaker 1: priced in that Novo Nordisk would continue the bidding war,
- 2:45Speaker 1: maybe raised Met Sarah's valuation further, but they declined to
- 2:49Speaker 1: give any further offer over the weekend. So it does
- 2:51Speaker 1: seem like Pfizer has sealed the deal. In a deal
- 2:54Speaker 1: it could be worth up to ten billion dollars now.
- 2:56Speaker 1: Pfeiser and Nova Nordisk have been heavily eyeing this obesity
- 3:01Speaker 1: startup to aid their efforts in the drug space Pfizer's
- 3:04Speaker 1: own in house drug failings earlier this year, and then
- 3:07Speaker 1: Novo is also dealing with the loss of its patent
- 3:09Speaker 1: for ozepic. So perhaps the saga is over, But does
- 3:12Speaker 1: seem like Matsara is losing in today's trade, down fifteen percent.
- 3:15Speaker 3: And finally, Valerie looks like robin Hood Markets is making
- 3:19Speaker 3: some news this morning.
- 3:20Speaker 1: It is so Robinhood is up four percent now. Cryptolink
- 3:23Speaker 1: stocks are generally doing well. Bitcoin is rallied over the weekend,
- 3:26Speaker 1: up over two and a half percent since Friday. But
- 3:28Speaker 1: there's also a very interesting report out from the FT
- 3:31Speaker 1: that Robinhood plans to offer investors access to private AI
- 3:36Speaker 1: companies via a new fund managed by its subsidiary, Robinhood Ventures.
- 3:41Speaker 1: The CEO was saying to the FT, he is keen
- 3:44Speaker 1: to deliver exposure to private AI companies for its customers,
- 3:47Speaker 1: regardless of this bubble chat. He wants to do it
- 3:50Speaker 1: to keep relevant with their customer base. And we're seeing
- 3:53Speaker 1: the stock react positively this morning, up four percent for
- 3:56Speaker 1: robin Hood.
- 3:57Speaker 2: This stock mover's report from Bloomberg Radio. Check back with
- 4:02Speaker 2: us throughout the day for the latest roundup of companies
- 4:04Speaker 2: making news on Wall Street and for the latest market
- 4:07Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 4:12Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
- 4:15Speaker 2: the Bloomberg Business app.